BioSpace News Archive

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2023 and provide a corporate strategic update on Monday, May 15, 2023, after the close of trading.

Simulations Plus, Inc., a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced the release of a new integrated pulmonary software and services package.

Jaguar Health, Inc. today announced that the Company has launched an artificial intelligence-powered web portal for U.S. healthcare professionals to support patient access to Mytesi (crofelemer).

Biotricity Inc. announced that its Founder & CEO Waqaas Al-Siddiq will be speaking at the World Heart Summit 2023 taking place in Geneva, Switzerland on May 19-21.

Spago Nanomedical The Annual General Meeting of Spago Nanomedical AB was held , May 10, 2023.

G-Tech Medical today announced an oral presentation of an abstract entitled A Novel, Non-invasive, 6-day Wireless Motility Patch System Demonstrates Unique Myoelectrical Patterns in Patients with Functional Dyspepsia, Gastroparesis, and Vomiting at the recent Digestive Disease Week Annual Meeting held in Chicago May 6-9.

Bioventus Inc., a global leader in innovations for active healing, announced that it has signed a definitive agreement to sell its Wound business, including the skin substitutes TheraSkin and TheraGenesis, to LifeNet Health.

Sommetrics, a private company developing solutions to improve sleep health by providing innovative first in class products to treat sleep apnea, today announced that it made a presentation at the 22nd Annual Needham Virtual Healthcare Conference.

ISPOR 2023 Presentation Shows 33% Lowered Costs with Gleolan Compared to Conventional White Light Surgery

Pulse Biosciences, Inc. today announced that it intends to deliver an irrevocable notice of redemption, on or about May 15, 2023, to redeem all of the common stock warrants that were issued as part of its June 9, 2022 rights offering which are still outstanding as of June 16, 2023.